ACRS beat EPS expectations by 28.06%
Aug 21, 2024, 9:33 AM
0.00%
What does ACRS do
Aclaris Therapeutics, Inc., a biopharmaceutical company based in Wayne, Pennsylvania, specializes in developing drugs for medical and aesthetic dermatology and immunology. Established in 2015, the company operates in therapeutics and contract research, focusing on immuno-inflammatory diseases and providing laboratory services.
Aclaris Therapeutics (ACRS) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, Aclaris Therapeutics's actual EPS was -$0.15, beating the estimate of -$0.21 per share, resulting in a 28.06% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.